Soligenix
SNGX
#10222
Rank
A$23.98 M
Marketcap
A$2.38
Share price
-1.86%
Change (1 day)
-56.39%
Change (1 year)

Soligenix (SNGX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$5.56 Million

According to Soligenix's latest financial reports the company's total liabilities are A$5.56 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Soligenix - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$7.79 M-27%
2023-12-31A$10.67 M-56.62%
2022-12-31A$24.61 M10.52%
2021-12-31A$22.27 M6.05%
2020-12-31A$21 M132.73%
2019-12-31A$9.02 M50.95%
2018-12-31A$5.97 M44.5%
2017-12-31A$4.13 M3.92%
2016-12-31A$3.98 M-60.83%
2015-12-31A$10.16 M17.04%
2014-12-31A$8.68 M-22.8%
2013-12-31A$11.25 M913.13%
2012-12-31A$1.11 M-20.52%
2011-12-31A$1.39 M-25.72%
2010-12-31A$1.88 M39.65%
2009-12-31A$1.34 M-31.41%
2008-12-31A$1.96 M43.87%
2007-12-31A$1.36 M-57.22%
2006-12-31A$3.19 M26.58%
2005-12-31A$2.52 M-6.4%
2004-12-31A$2.69 M98.74%
2003-12-31A$1.35 M-50.82%
2002-12-31A$2.75 M-89.71%
2001-12-31A$26.78 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Emergent BioSolutions
EBS
A$1.32 B 23,669.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.37 B 1,786,376.51%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$174.03 B 3,128,603.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.87 B 3,071,892.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$65.95 M 1,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$18.29 M 228.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.06 B 882,003.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel